Fatty Acids in Non-Alcoholic Steatohepatitis: Focus on Pentadecanoic Acid

PLoS ONE - United States
doi 10.1371/journal.pone.0189965
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

1. Fatty Liver and Non-Alcoholic Steatohepatitis

Internal Medicine
Internal MedicineMedicine
2007English

Portal Lymphadenopathy Predicts Non-Alcoholic Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease

PLoS ONE
Multidisciplinary
2018English

Systematic Review: The Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2010English

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Modulation in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Nuclear Receptor Research
2017English

Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis

Clinics in Liver Disease
Hepatology
2009English

Protective Effect of Isochlorogenic Acid B on Liver Fibrosis in Non-Alcoholic Steatohepatitis of Mice

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis

PLoS ONE
Multidisciplinary
2010English

Patient-Reported Outcomes and the Economic Effects of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis - The Value Proposition

Hepatology
MedicineHepatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy